Skip to content

Biomarkers Estimation in Stroke

Diagnostic evaluation of Plasma GFAP for the rapid differentiation between Ischemic Stroke and Intracerebral Hemorrhage - BE FAST

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/07/015026
Enrollment
200
Registered
2018-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Having neurological symptoms at hospital admission suspicious for acute stroke

Interventions

None listed

Sponsors

Christian Medical College
Lead Sponsor
Johann Wolfgang Goethe University
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Presence of neurological symptoms at hospital admission suspicious for acute stroke 2. Time interval from symptom onset to study inclusion

Exclusion criteria

Exclusion criteria: 1. Ischemic stroke, intracerebral hemorrhage or transient ischemic attack within the last three months 2. Patients participating in other stroke trials/research 3. Known history of brain tumor at any time in patient history 4. Evidence for traumatic brain injury with the last 3 months 5. Participant in another stroke study 6. Informed consent not given

Design outcomes

Primary

MeasureTime frame
1. Diagnostic accuracy (sensitivity, specificity, positive predictive value, negative predictive value) of GFAP for differentiating patients with ICH from patients with ischemic stroke (including TIA) and stroke mimics. 2. Gold standard is the diagnosis of ICH, ischemic stroke (including TIA), or stroke mimic as determined at the end of hospital stay based on all available information. Timepoint: 1 month after the end of recruitment phase

Secondary

MeasureTime frame
1. Analysis stratified for patients with a moderate to severe neurological deficit (NIHSS 9). 2. Analysis stratified for patients with different time windows (2 h, 2 to 6 h, 6 to 12 h) from symptom onset to blood withdrawal. 3. Correlation between GFAP values and ICH volume and location. Timepoint: At the time of result analysis

Countries

India

Contacts

Public ContactDr Jeyaraj Durai Pandian

Christian Medical College

jeyarajpandian@hotmail.com9915784750

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026